Inflammatory and tolerogenic myeloid cells determine outcome following human allergen challenge.
Voskamp AL, Tak T, Gerdes ML, Menafra R, Duijster E, Jochems SP, Kielbasa SM, Kormelink TG, Stam KA, van Hengel ORJ, de Jong NW, Hendriks RW, Kloet SL, Yazdanbakhsh M, de Jong EC, Gerth van Wijk R, Smits HH.
Voskamp AL, et al. Among authors: gerth van wijk r.
J Exp Med. 2023 Sep 4;220(9):e20221111. doi: 10.1084/jem.20221111. Epub 2023 Jul 10.
J Exp Med. 2023.
PMID: 37428185
Free PMC article.